Ardelyx

Ardelyx, Inc. is a biopharmaceutical company based in Waltham, Massachusetts, founded in 2007. The company focuses on discovering, developing, and commercializing innovative medicines aimed at addressing significant unmet medical needs in cardiorenal, gastrointestinal, and metabolic disorders. Ardelyx is dedicated to improving patient lives through pioneering science and novel therapies. The company develops proprietary small molecule therapeutics and has key marketed products, including tenapanor, which is used for treating irritable bowel syndrome with constipation (IBS-C) and hyperphosphatemia in patients with end-stage renal disease. Ardelyx also offers ArdelyxAssist, a patient support program designed to enhance access and adherence to its therapies. The company serves patients in the United States and collaborates with other pharmaceutical and biotechnology companies to co-develop small molecule drugs, highlighting its commitment to innovation and addressing critical gaps in patient care.